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1. Introduction 
Proper definition, recognition and classification of chronic gastritis are fundamental for its 
successful therapy. Gastric inflammation based on clinical/endoscopic classification is not a 
pathomorphologically homogenous diagnostic group. From histopathological point of view, 
it seems most likely that chronic gastritis is characterized by morphological indices of 
chronic inflammatory changes in different parts of gastric mucosa. Chronic superficial 
gastritis is associated with lymphocyte and plasma cells infiltrate of the foveolar part of 
gastric mucosa. Chronic gastritis is associated with the inflammatory cell infiltrate 
predominantly consisting of lymphocyte and plasma cells in total gastric mucosa.  Current 
classification of chronic gastritis and the worldwide accepted knowledge of the natural 
history of gastritis are combined in the 1994 Houston-updated Sydney System.  Helicobacter 
pylori is by far the most important etiologic factor in chronic gastritis. Helicobacter pylori 
infection accompanies chronic (or chronic active) and/or superficial (or atrophic) gastritis in 
about 90% and the process of development of the lesions usually lasts from 20 to 40 years. 
Chronic gastritis, especially caused by Helicobacter pylori, is accompanied by disturbances 
in secretion of HCL, pepsinogen as well as gastrin and somatostatin. It has been reported 
that Helicobacter pylori induces increased apoptosis and hyperproliferation of gastric 
epithelial cells. These changes (increased apoptosis, hyperproliferation and secretion 
disturbances) are reduced after Helicobacter pylori eradication. It is worth mentioning that 
regenerative abilities of gastric mucosa glandular epithelium cells are the main mechanism 
determining their right functions concerning both integrity of the mucosa and normal 
function of its all epithelial cellular elements. In chronic atrophic gastritis, a significantly 
higher percentage of cells in mitotic phase is found as compared to both normal condition 
and chronic superficial gastritis. Moreover the proliferative activity of glandular epithelial 
cells is directly proportional to the increasing degree of gastric mucosa atrophy. An increase 
in proliferative activity of glandular epithelium in gastric mucosa was also observed in 
chronic, particularly atrophic, gastritis, independently of its etiology. There is strong 
evidence on possible progression of changes from chronic atrophic gastritis to intestinal 
metaplasia, dysplasia and finally adenocarcinoma. It is worth mentioning that not much 
attention has been drawn to the importance of the examination of regenerative activity of 
the gastric mucosa epithelium, neuroendocrine and immune cells for the study of chronic 
gastritis pathogenesis.  
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2. Evaluation of the morphological criteria used so far for diagnosis of 
superficial and atrophic chronic gastritis 
Gastritis is a disorder generally acknowledged by both clinicians and pathomorphologists. 
At the same time it is the most frequently overused diagnosis mostly by clinicians and less 
commonly by pathomorphologists. On one hand, gastritis is considerably frequently 
diagnosed even in seemingly trivial complaints such as acid indigestion or dyspepsia. On 
the other hand, is should be taken into consideration that differently advanced histological 
indices of gastritis are diagnosed in about 40% of people with normal endoscopic picture of 
gaster and no digestive track complaints (Sipponen, 1992). It is worth noticing that 
according to population prognosis, about 50% of people would develop gastritis within 
their lives, mainly in occupational period. Therefore, the problem involves not only overuse 
of this type of diagnosis but also its omission in evaluating healthy people’s condition. 
Based on the said assumption, it can be concluded that the fundament for diagnosing and 
classifying gastritis should be exclusively endoscopy with collection of samples and the final 
evaluations of the sample in histopathological test.   
From pathomorphological standpoint gastritis could be defined as a syndrome caused by 
heterogenic group of pathogenic factors which lead to damage to gastric mucous membrane 
manifested by acute, chronic or mixed inflammatory reaction (Strickland, 1990). 
Scandinavian authors claim that chronic gastritis (CHG) is an age-independent progressing 
disease whose onset has a form of a superficial inflammatory infiltrate (gastritis chronica 
superficialis), through gradual loss of gastric proper glands (gastritis chronica atrophica), to 
complete atrophy of these glands inclusively (atrophia mucosae ventriculi; severe atrophic 
gastritis).  Development of morphology studies on CHG was inseparably connected with 
progress within endoscopic techniques as well as methodics of pathomorpholgical tests. The 
following events had significant influence on gastropathomorphology process: introduction 
of endoscopic examination (beginning of 50s of the previous century), immunological tests 
(end of 50s of the previous century), improvement of endoscopic techniques (beginnings of 
70s) , “rediscovery” of Helicobacter pylori in gastric mucous membrane and correlation of 
its presence with gastric lesions (beginning of 80s) (Strickland, 1990) as well as development 
of immunohistological techniques (beginning of 80s) and current development of molecular 
biology methods and molecular cytogenetics, especially the use of this type of examination 
techniques in pathomorphology.  
The term “gastritis” (quote by Misiewicz et al., 1990) was first introduced in 1728 by Stahl 
who probably did not expect that in further years it would become the most commonly 
made diagnosis and at the same time one of the least clear ones.  As it was mentioned above, 
classification of inflammation in gastric mucous membrane, especially chronic one, should 
be based only on morphological indices of its damage while the majority of current 
classifications of gastritis is to a great extent based on a pathomorphological diagnosis 
which is a combination the following criteria: etiologic, topographic and, according to some 
people, also immunological and histopathological (Correa, 1988; Dixon et al., 1996; 
Misiewicz et al., 1990; Owen, 1996; Price, 1991, 1999; Strickland, 1990; Tytgat, 1991).  
Therefore, this point of view lacks clear division into functional changes and morphological 
changes. In other words, the difference between the cause and the effect, morphological in 
this case, is blurred.  
The first gastritis classification based on histopathological examination of samples collected 
by the so called blind biopsy and samples collected during surgical procedures was created 
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by Schindler in 1947.  Due to inability to define anatomotopography of the collected gastric 
mucous membrane sample Schindler first divided inflammation into superficial and 
atrophic and next distinguished the group of hypertrophic inflammations. Moreover, he 
was the first to use the term gastritis chronica with full awareness in its today’s meaning 
(quote by Misiewicz et al., 1990).  
The best recognition was given to the gastritis classification created by Whitehead in 1972 
(Whitehead et al., 1972).  It is based only on classic pathomorphological criteria and involves 
separate diagnosis for region of pylorus, corpus, cardia and gastric mucous membrane 
welding area. Similarly to Schindler’s classification, Whitehead divided gastritis into 
superficial and atrophic. However, Whitehead distinguished two forms for each of them: 
active form with presence of granulocyte infilters in epithelium and/or interstitium and a 
non-active form with inflammatory infiltration from lymphoidal and plasmatic cells located 
in lamina propria. Atrophy of mucous membrane proper glands was evaluated in a three-
level scale (mild, moderate and sever) as well as, in justified cases, the presence of intestinal 
and pseudopyloric metaplasia was noted.  
One year later Strickland and McKay modified CHG classifications by combining etiologic 
and immunologic data with pathomorphological and anatomotopographic indices and by 
distinguishing type A and B gastritis (Strickland & Mackay, 1973). Type A gastritis referred 
only to gastric corpus and was accompanied by pernicious anaemia, while in the case of 
type B gastritis the lesions were localized in antral regions.  In the same year (Glass & 
Pitchumoni, 1975) Glass and Pitchumoni completed the first classification by adding AB 
type gastritis which included types of extensive involvement of mucous membrane of the 
corpus and prepyloric regions. The cases of concurrent presence of antibodies of oxyntic cell 
were defined as AB-plus CHG.  
In 1980 (Correa, 1980) Correa introduced etiopathogenetic element into histopathological 
diagnosis by dividing CHG into: autoimmunization CHG with pernicious anaemia; 
hypersecretion CHG connected with duodenal ulceration and environmental CHG 
dependent mainly on the diet but also on geographic localization. In 1988 (Correa, 1988) the 
same author modified his previous classification by dividing CHG into: diffuse antral 
gastritis, diffuse corporal gastritis and multifocal atrophic gastritis. Next, in 1992 along with 
Yardley (Correa & Yardley, 1992) in continuation of completing and developing the 
previous versions of his classification of CHG he divided the inflammation into: gastritis 
with and without atrophy of gastric proper glands.  In the group of non-atrophic gastritis he 
distinguished superficial CHG as initial condition and/or stationary as well as diffuse CHG 
connected with prepyloric region. As regards diffuse inflammation of prepyloric regions, it 
might be accompanied by duodenal and pyloric ulcer. Moreover, in this case Helicobacter 
pylori is the first cause and the following are not observed: gland atrophy, intestinal 
metaplasia or carcinogenesis. Among the types of atrophic gastritis he distinguished the 
following: diffuse CHG connected with the corpus, autoimmunization CHG accompanied 
by pernicious anaemia and multifocal CHG usually affecting mucous membrane in lower 
regions of gastric lesser curvature. Multifocal CHG can be accompanied by duodenal ulcer 
and is frequently followed by occurrence of intestinal metaplasia of mucous membrane. 
Moreover, cases of atrophic multifocal CHG are accompanied by increased risk of neoplasm 
development.  
The study by Marshall from 1983 (Marshall, 1983) on Helicobacter pylori revolutionized the 
view on CHG etiology, which, among others, contributed to creation of a new CHG 
classification finally accepted in Sydney in 1990 (Misiewicz et al., 1990; Price, 1991). 
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Basically, this classification included all the previous CHG divisions, yet an etiology factor 
was added as a permanent element of pathomorphological diagnosis. In this classification 
the previous CHG morphological quantifications were exchanged with evaluation of 
morphological change advancement level according to a four-level scale. One of the most 
important practical conclusions in the Sydney classification is a necessity of routine 
collection of a particular number of samples (four; two from the corpus and two from the 
antrum, from both anterior and posterior walls) and what is equally important - fixation of 
those samples in properly labeled separate containers. Moreover, it was clearly stated that 
any other lesion confirmed by endoscopic examination requires collection of additional 
samples from the muscularis mucosae depth.  
It should be noted that chronic gastritis is not characterized by a specific clinical or 
endoscopic picture. This also refers to particular most common etiologic factors whose 
action is not characterized by a defined syndrome complex. Moreover, it is worth adding 
that there is no correlation between endoscopic picture of gastric mucous memrane and 
histopathological examination, especially in the case of mild changes. The most significant 
issue as regards this aspect of CHG diagnostics is the fact that even in 40% of CHG cases no 
endoscopic changes or presence of CHG microscopic indices of various level of 
advancement are observed. These dependencies lead to the issue called routine collection of 
samples in every endoscopy as well as relevant problems, not only connected with high 
cost.  
From histopathological standpoint, the Sydney system distinguishes three basic types of 
inflammation: acute, chronic and special. Acute inflammation is usually characterized by 
subclinical course, which is rarely used as an indication to perform stomach endoscopy. 
Special forms of gastritis are not frequently examined by taking biopsy as this type of 
disorder is extremely rare. Therefore, routine gastrologic biopsy material is most frequently 
connected with cases of non-specific CHG of considerably repeatable picture of 
pathomorphological changes due to the fact that immunological mechanisms of reaction to 
different pathogens in gastric mucous membrane are generally not various. Therefore, the 
Sydney system included all the microscopic indices of gastric mucous membrane changes 
that are present in CHG and were described before 1990. Some of the indices are as follows: 
inflammatory infiltrate (consisting of lymphoid and plasmatic cells), atrophy of gastric 
proper glands, active inflammatory process (measured by the number of neutrophils and 
eosinophils), intestinal metaplasia and intensity of Helicobacter pylori colonization in 
gastric mucous membrane evaluated in a 4-level- scale (none, mild, moderate and severe). 
Other CHG microscopic changes, such as mucus content in cells, degenerative changes of 
epithelial cells, hyperplasia of foveolar layer glands, stroma oedema, erosions, fibrosis and 
dilation of vascular lumen are evaluated only in terms of quality.  
According to the Sydney System, the following sites of sample collection in topographic part 
of pathomorphological diagnosis can be determined: antrum, corpus or the whole gaster 
(pangastritis, antrum predominant, corpus predominant). Therefore, in the case of collecting 
samples from only one anatomotopographic region the diagnosis based on the Sydney 
system is not possible (incomplete examination). The etiologic part, which is to a possible 
extent defined by a clinician, includes: Helicobacter pylori (currently the most common 
cause), autoimmunization, drug-induced disorder as well as infectious etiology (bacterial, 
viral, parasite, fungal). In the case of no evident cause (etiology) CHG is defined as 
idiopathic inflammation.  
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The assumptions described above suggest, among others, that the Sydney system replaced 
classic histopathological diagnosis which involves diagnosis based on miscroscopic indices 
of changes only by means of quantitative evaluation of the advancement level of 
inflammatory miscroscopic indices. This interpretation of changes allows for quantitative 
consideration of morphological changes in CHG (necessary for e.g. scientific works). 
However, it does not allow for making an accurate histopathological diagnosis which would 
allow the clinician to draw prognostic and therapeutic conclusions.   
This approach towards pathomorphological phenomena in the Sydney system was a 
probable reason for excluding generic diagnosis - gastritis chronica superficialis (CHSG) 
which, according to opinion of both this work’s and other authors, was very significant. 
Superficial chronic gastritis is characterized by presence of inflammatory infiltrate built up 
of lymphoid and plasmatic cells localized in 1/3 of the upper part of gastric mucous 
membrane, namely on foveolar layer. This inflammation usually affects also the layer of  
stem glands. Comparing to CHSG of antral and pyloric parts,  corpus of the gaster is a site of 
a more common CHSG development. A key diagnostic element of CHSG is evaluation of 
inflammatory infiltrate localization which is analyzed in terms of strictly defined 
histotopographic structures of gastric mucous membranes. Therefore, it is a very accurate 
criterion which does not require additional examination tools and/or other supporting 
classifications/scales. It is worth mentioning that this type of diagnosis occurred in all the 
CHG classifications compiled before 1900 (Correa, 1980, 1988; Correa & Yardley 1992; 
Whitehead, 1972). Most authors consider CHSG as the initial part of CHG. As regards the 
difference between the two disorders, in the case of CHG the inflammatory infiltrate of 
similar cellular composition affects also deeper parts of gastric mucous membrane and 
reaches muscularis mucosa. In the presence of granulocytes (neutrophils and/or 
eosynophils) in the inflammatory infiltrate composition, active inflammation - CHSG activa 
and CHG activa - is diagnosed.  
One of the most significant advantages of the Sydney classification is that it obliges 
clinicians and pathomorphologist to cooperate in the process of diagnosis gastritis from the 
very beginning and it makes the clinicians responsible for the etiologic and 
anatomotopographic part of the diagnosis. Clinicians frequently have justified doubts as 
regards etiology of the observed gastric lesion. However, establishment of topography of the 
collected oligobiopoints as well as their fixation in separate containers can in no way be 
problematic. Following its compilation, the Sydney classification was not fully accepted, 
especially by American authors (Correa & Yardley, 1992).  This was, among others, the 
reason for its revision which was finally performed in Houston in 1994 (Dixon et al., 1996). 
The most significant element of the revision was giving a suitable role to classic 
histopathological nomenclature in making CHG diagnosis, especially regarding non-
atrophic CHG, particularly for gastritis chronica superficialis which was “forgotten” in the 
Sydney classification (Correa & Yardley, 1992). Visual analogue scale was added to the 
quantitative evaluation of histopathological changes. Also, the following rule of routine 
collection of samples from gastric mucous membrane, slightly different from the Sydney 
classification, was suggested in Houston: 
• two antrum samples; 2-3cm, from pylorus from lesser and greater curvature, 
• two corpus samples; 8cm, from cardia from lesser and greater curvature, 
• one sample from the region of angular incisure 
• five samples from angular incisure for comparable evaluation of intestinal metaplasia 
and/or dysplasia level. 
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The authors also recommend HE and PAS with Alcjan Blue as a routine staining next to 
Helicobacter pylori identification (Giemsa’s method).  
This vast work from Houston, apart from the revision of the Sydney system, contains a 
number of detailed and valuable information on a wide range of aspects connected with 
cooperation between endocsopist and pathomorphologist and thus, it is suggested as a 
fundamental educational material for both parties. The modified Sydney classification 
causes different reactions among pathomorphologists –full acceptation (Chen et al., 1999; 
Wyatt, 1995) and a certain reserve (Guarner et al., 1999), especially with respect to 
implementation of the classification in pediatric gastropathology (Cohen et al., 2000). 
However, the authors supporting the concept of Sydney classification claim that this 
conceptual direction of CHG classification will be maintained. They are awaiting for the 
nearest non-histopathological criterion, namely dependencies arising from potential effects 
of using vaccination against Helicobacter pylori (Price, 1999).   
One of the latest complete divisions of gastritis was published by Appelman in 1994 
(Appelman, 1994). Traditional division into acute and chronic disease was maintained. The 
following were distinguished from chronic gastritis: inflammation connected with 
Helicobacter pylori and atrophy gastritis, lymphocitar gastritis – also called “chemical” and 
focal gastritis. Helicobacter pylori related gastritis, the most common one, is defined 
variously by different authors (Axon, 1992; Borchard, 2001; Correa, 1980, 1988; Glass & 
Pitchumoni, 1975; Green & Graham, 1990; Sipponen, 1989, 1992; Strickland & Mackay, 1973; 
Whitehead et al., 1972). Commonly used synonyms are as follows: gastritis chronica diffusa 
antralis, gastritis chronica typus B, gastritis chronica activa antralis, gastritis chronica non 
specifica and gastritis typus hypersecretions. Many publications (Arkkila et al., 2006; Axon, 
1992; Correa & Yardley, 1992; Green & Graham, 1990; Marshall, 1983; Sipponen, 1992; Zhang 
et al., 2005a, 2005b) clearly confirmed that Helicobacter pylori causes chronic gastritis by 
affecting mainly prepyloric part of the stomach. It can lead to atrophy of gastric proper 
glands, cancer and less frequently to lymphoma. It usually accompanies duodenal ulcer. Its 
morphological indices are inflammatory infiltrates of neutrophils localized on the foveolar 
layer stroma of gastric mucous membrane in the case of acute gastritis. Chronic gastritis is 
characterized by an infiltrate of lymphoid cells, plasmatic cells and acidophilic granulocytes. 
Moreover, it is accompanied by lymphadenoplasia foci and the infiltrate affects the whole 
gastric mucous membrane (Appelman, 1994; Axon, 1992; Correa, 1988; Marshall, 1983; 
Misiewicz et al., 1990; Price, 1991; Sipponen, 1992; Strickland, 1990; Wyatt, 1995). 
As regards autoimmunization inflammation, it is frequently defined as gastritis 
autoimmunogenes, gastritis chronica atrophica typus A, gastritis chronica typus A and 
gastritis chronica diffusa corporis. It is most frequently observed in Scandinavia and in 
northern areas of Europe. This inflammation affects gastric corpus and can be accompanied 
by: pernicious anaemia, autoimmunization Hashimoto thyroiditis, diabetes, adrenal 
insufficiency and thyroid function disorders. Common complications are stomach cancer 
and carcinoid. However, it is assumed that enterohormonal disorders (hypergastrinemia) 
which accompany carcinoid development are initiated by achlorhydria in the course of 
inflammation (Appelman, 1994; Strickland, 1990). 
Interestingly, focal atrophic gastritis is more frequently observed in the USA and Japan. Its 
most common synonyms are: gastritis chronica atrophica typus B or environmental gastritis. 
In terms of frequency of occurrence it affects lesser curvature, prepyloric region and gastric 
corpus. The most serious complication is cancer, mainly intestinal (Correa, 1980, 1988; 
Correa & Yardley, 1992).   
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Lymphocitar gastritis can be divided into the previously distinguished types of 
inflammation: gastritis chronica superficialis, gastritis chronica erosiva, gastritis 
varioliformis and morbus Menetrier. Basic morphological index of the lesions is an infiltrate 
which consists mainly of lymphocytes localized within superficial epithelium of gastric 
mucous membrane foveolar layer. This group comprises lesions of gastric mucous 
membrane which accompany among others celiac disease (Appelman, 1994; Price, 1991; 
Wyatt, 1995). 
The so called chemical gastritis is by some authors also referred to as: “chemica” 
gastropathy, gastritis refluxiva, gastritis biliaris, gastritis postmedicamentosa. Basic 
morphological indices of this inflammation are: proliferation of foveolar layer , decreased 
mucous secretion, stroma oedema with low inflammatory reaction  (Appelman, 1994; 
Borchard, 2001; Strickland, 1990; Wyatt, 1995). According to both the authors as well as 
other authors (Borchard, 2001; Dixon et al., 1996), the number of mixed CHG cases, in which 
some of the most significant components are microscopic indices of chemical gastritis, is 
increasing (or they are more frequently diagnosed). 
According to pathomorphological standpoint, the authors of this work, following prior 
mental, substantial and emotional acknowledgement of potential addresses, assume and 
suggest implementation of CHG classification based almost exclusively on 
pathomorphological criteria acknowledged also by other authors. Histopathological 
diagnoses used in this classification contain data on severity and distribution of 
inflammatory infiltrate, its activity and condition of potential atrophy of gastric proper 
glands (gastritis chronica superficialis activa et nonactiva; gastritis chronica activa et nonactiva, 
gastritis chronica atrophica et atrophia mucosae ventriculi) as well as they take into consideration 
also histotopographical data on the examined samples (CHG antralis, corporis, fundi, cardiae, 
pylori).  In every justified case, dysplasia level is evaluated as well as the presence of : 
glandular hyperplasia of foveolar layer, intestinal and pseudopyloric metaplasia. Focal gastritis is a 
kind of systemic disease which causes among others lesion in the gaster and in characterized 
by specific morphological indices of diagnosis CHG type.  The suggested classification also 
comprises other CHG types enumerated by Appelman: lymphocitar, the so called chemical 
CHG, and gastritis chronica erosiva. According to the Sydney classification system, 
identification of Helicobacter pylori is obligatorily taken into consideration in histological 
evaluation along with the assessment of this microorganism. However, etiopathogenetic 
standpoint is a supplementary element found in additional comment to the basic 
histopathological diagnosis.  
A number of factors, such as different classifications, the increasing number of reports on 
the Sydney classification analysis, both initial and updated version, and the opinions of 
cooperating clinician groups, lead to a conclusion similar to Appelman’s view: the best CHG 
classification is the one that both provides the best possible and the clearest contact between 
clinician and pathologist and most of all facilitates effective diagnostic and therapeutic 
management.  
3. Analysis of the proliferative activity of gastric mucosa glandular epithelium 
in relation to the chronic gastritis type 
Regenerative abilities of glandular epithelium cells of gastric mucosa constitute the main 
mechanism determining their correct functions concerning both integrity of the mucosa and 
normal function of all its epithelial cell elements (Goodlad & Wright, 1995). One of more 
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important cell elements in this process are mucous cells of the cervical part of gastric glands 
(Goodlad & Wright, 1995; Hellander, 1981) and also isthmus cells, as stressed by other 
authors (Goodlad & Wright, 1987). Mucous cells of the cervical part of gastric glands are 
present singly and/or in cellular clusters in the epithelium of the cervical region of gastric 
glands (Goodlad & Wright, 1995) and are usually invisible after routine H-E staining. These 
cells, besides purely secretory function, are the pool of cells that are the source for 
regenerating cells of the glandular epithelium, among which the presence of primary 
alimentary tract cells for gastric mucosal epithelium (so called stem cells) can be observed 
(Goodlad & Wright, 1995; Solcia et al., 1979). 
One of more frequently used immunocytochemical markers for cells in proliferation phase is 
proliferating cell nuclear antigen (PCNA) (Goodlad & Wright, 1995). It is a protein of 36 kDa 
mass, co-factor for DNA delta-polymerase and it participates in DNA synthesis (S-phase of 
cell cycle) and DNA repair (Keleman, 1997; Waseem & Lane, 1990). PCNA usually 
undergoes overexpression in conditions connected with activity of growth factors (Hall et 
al., 1990). PCNA expression is genetically regulated, and mRNA PCNA is present in both 
proliferating cells and those in resting phase (Hall et al., 1990). 
The control of glandular epithelium regeneration centres in the alimentary tract, including 
the stomach is multidirectional, starting from simple negative feedback with damaged 
superficial epithelial cells, finishing on the effect of intragastric environment (Goodlad & 
Wright, 1995). The main point of this regulation includes hormonal, neuropeptide, peptide 
and genetic actions with simultaneous influence of immune-nervous factors and 
mesenchymal components on the stroma (Goodlad & Wright, 1995). Apart from  the group 
of factors associated with enteroglucagon, a particular role in the stimulation of regenerative 
processes regulation in gastric mucosa is played  by gastrin (Goodlad & Wright, 1995; 
Walsh, 1990). It should be stressed that drugs influencing gastrin level also exert indirect 
influence on glandular epithelium proliferation in gastric mucosa (Havu, 1986). 
Prostaglandins, in their broad spectrum of activity, have the ability to stimulate proliferation 
of glandular epithelial cells of gastric mucosa, including also acceleration of these cells’ 
migration (Goodlad et al., 1989). As regards the growth factors, epidermal growth factor 
(EGF) plays the main role in the regulation of regeneration processes in gastric mucosa 
(Weaver & Walker, 1988).  
Most of the regenerating cells of glandular epithelium migrate along the wall of foveolar 
layer glands to the surface of gastric mucosa during about seven days (Lee, 1985). This 
migration far less frequently occurs deep into gastric glands and takes longer time, i.e. about 
200 days (Hattori, 1976). As it is commonly known, cell division includes four phases, 
making up jointly the so called cell cycle (cell cycle phases: G1, S, G2 and M), and the 
duration of this cycle depends mainly on the duration of the G1 phase (Goodlad & Wright, 
1995; Preston-Martin et al., 1990). A cell may go out of the cell cycle to enter G0 resting state 
or may pass to maturation phase. It has been disclosed, however, that in the case of 
alimentary tract mucosal cells, the resting state is practically not observed, perhaps with the 
exception of the large bowel (Goodlad & Wright, 1995). 
Apoptotic regulations of these cells, and, in the first place, genetically determined 
regulations, play, besides regenerative abilities of the epithelium, an important role in the 
homeostatic process of gastric mucosa (Goodlad & Wright, 1995; Oren, 1992; Yanagihara & 
Tsumuraya, 1992). Growth factors and other factors, for example c-myc, bcl-2, p53, TGF-
beta, TNF and other cytokines participate in the apoptotic process (Oren, 1992; Yanagihara 
& Tsumuraya, 1992).  
www.intechopen.com
 
Chronic Gastritis 
 
83 
Proliferative activity of the glandular epithelium of stomach corpus and fundus mucosa is 
normally located in the cervical part of gastric glands, while in the prepyloric part it 
occupies the middle 1/3 part of the mucosa where also G cells are present (Ito et al., 1986). 
In this part an intensive expression of chromogranin-A-positive cells can also be observed. 
In own studies it has been demonstrated that these regions are the place where the most 
intensive PCNA expression is observed. Most authors think that proliferative activity of 
glandular epithelial cells in gastric mucosa increases with Helicobacter pylori colonization 
(Bechi et al., 1996; Jang & Kim, 2000; Lynch & Axon, 1995; Panella et al., 1996), which is 
particularly visible in the corpus (Bechi et al., 1996). On the other hand, after eradication, the 
proliferative activity returns to normal (Lynch & Axon, 1995). According to other authors, 
bile participates in the increase of gastric glandular epithelial activity in the course of 
H.pylori colonization (Lynch & Axon, 1995), while the markers of this activity are observed 
mainly within the epithelial zone of foveolar layer glands (Bechi et al., 1996). It is worth 
mentioning that other authors (Ito et al., 1986) found a deepening of proliferative zone 
within gastric glands in the same gastric mucosal inflammatory conditions, with 
accompanying significant reduction of EC cell number. According to some authors, 
increased proliferative activity of gastric mucosal glandular epithelium, particularly that 
measured by PCNA expression, in the course of chronic inflammatory conditions and 
H.pylori colonization may be even the marker of risk of malignancy development (Irazusta 
et al., 1998; Panella et al., 1996). Other authors (Diebold et al., 1998), however, demonstrated 
that during H.pylori colonization a decrease in the number of argyrophilic cells occurs along 
with simultaneous reduction of their proliferative potential. This seems to be in concordance 
with the studies in which an inhibitory effect of VacA on the proliferation of epithelial cells 
of gastric mucosal glands through impairment of their migration ability was demonstrated 
(Ricci et al., 1996). The same authors also proved that another antigen, CagA, exerts no effect 
on the proliferative potential of gastric mucosal glandular epithelium. The results of these 
studies may be, in a certain way, compared with own studies according to which no 
significant influence of H.pylori colonization on proliferative activity of gastric mucosal 
glandular epithelium was demonstrated. An increase in proliferative activity of glandular 
epithelium in gastric mucosa was also observed in chronic gastritis, independently of its 
etiology (Bechi et al., 1996; Deschner et al., 1972; Irazusta et al., 1998; Panella et al., 1996). It 
was usually accompanied by a decrease in G cell count, including adrenomodulin-
containing cells (Kitani et al., 1999), particularly frequently when the gastritis was associated 
with atrophic lesions. According to the studies by other authors (Bielicki et al., 1993; Guerci 
et al., 1992),  a significantly higher percentage of cells in division phase is found in chronic 
atrophic gastritis as compared to both normal condition and to chronic superficial gastritis, 
and the proliferative activity of glandular epithelial cells is directly proportional to the 
increasing degree of atrophy. Other authors (Ito et al., 1986) noted that, together with 
intensification of inflammatory processes in gastric mucosa, the zone of increased 
proliferation of glandular epithelial cells involves also deeper layers of the lamina propria of 
gastric mucosa, and also. the number of ECn cells is reduced. It should be added that in 
hypergastrinaemia, the expression of neuroendocrine cells and their proliferative abilities 
increase but such changes were not observed during antisecretory treatment. No such 
hypergastrinaemia inducing effect was observed during activation of gastric mucosal 
inflammatory processes or in biomorphotic process. In the course of Helicobacter pylori 
colonization other authors (Jang & Kim, 2000) found intensification of both apoptosis and 
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proliferative activity of neuroendocrine cells, mainly G and D, correlated with gastritis 
activity and with the degree of H.pylori colonization.  
Own studies are partially in concordance with the observations described above since they 
demonstrated that proliferative zone of mucosal epithelial cells becomes deeper with 
intensification of inflammatory lesions but only in the case of stomach corpus. At this point, 
however, it should be noted that this applies only to males who have higher proliferative 
activity in this zone of mucosa as compared with females. Regardless of that, in own studies 
a significantly higher proliferative activity was found, but only in superficial gastritis, in 
relation to deep gastritis, which had not been described by other authors. Apart from this, it 
was demonstrated that changes of proliferative activity of gastric mucosal epithelium were 
independent of age, location (prepyloric part – corpus), and also Helicobacter pylori 
colonization in gastric mucosa. 
3.1 Conclusions (own studies) 
1. Chronic superficial gastritis coexists with significantly higher proliferative activity of 
gastric mucosal glandular epithelium, particularly in relation to the prepyloric part.  
2. Changes of proliferative activity of gastric mucosal glandular epithelium are 
independent of age, histotopography and H.pylori colonization.  
4. Assessment of the current status of neuroendocrine and immune cells for 
the study of pathogenesis of chronic gastritis 
Gastric mucosal neuroendocrine cells are usually located in the epithelial layer of the gastric 
glands in the corpus and prepyloric part, sometimes in their cervical zone, but they are 
never found in the superficial epithelium of the foveolar layer glands of gastric mucosa 
(Dayal, 1992; Kozlowski et al., 1993, 1995; Portela-Gomes & Grimelius, 1986). Modern 
classifications of gastric mucosal neuroendocrine cells tend to divide them according to 
anatomic-topographic location in the stomach (Bordi et al., 2000; Dayal, 1992; Tzaneva, 
2001). The following neuroendocrine cells are present in the mucosa of gastric corpus and 
fundus: ECL (enterochromaffin-like), D (somatostatin), ECn (enterochromaffin), X/A, D1, 
and P cells. ECL cells occur almost exclusively in gastric fundus mucosa. However, the 
prepyloric part of the stomach contains G (gastrin), D, and ECn cells. D cells produce 
somatostatin and are present almost in the whole alimentary tract and also in the pancreas 
(Canese & Bussolati, 1977). In course of their long cytoplasmic processes they exert 
paracrine effect on other neighbouring gastric mucosal cells (Larsson et al., 1984). At least 
20% of D cells have axon processes through which they are in contact with G cells in the 
prepyloric part  and parietal cells in gastric corpus mucosa (Larsson et al., 1984), inhibiting 
their secretory function. Moreover, D cells in the prepyloric part have specialised tubules 
through which they are in contact with gastric lumen (autoregulation with intragastric 
environment). D cells in gastric fundus mucosa have no such contact with stomach lumen 
(Fenoglio-Preiser, 1999). As far as now, no publications on correlations between gastric 
mucosa neuroendocrine and degree of chronic gastritis can be found in scientific literature.  
The applied own method of studying gastric mucosal neuroendocrine cells allowed for 
assessment of their count and rate of changes in the course of non-specific gastritis of 
various progression in a repeatable way. It is worth mentioning that on the basis of 
examination of one cross-section type it is possible to assess the most probable total count of 
a definite type of gastric mucosal neuroendocrine cells in a highly correlated way (about 
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95% confidence level). This type of histological quantitative examinations is very practical in 
routine histopathological diagnosis.  
Contrary to the results reported by other authors (Coupe et al., 1990; Tzaneva & Julianov, 
1999), changes concerning D cells and CgA cells located in the stomach corpus mucosa were 
found in own studies. The latter, however, demonstrated a significant decrease of D cell 
count in the oxyntic mucosa with simultaneous increase of CgA cell count in the prepyloric 
mucosa. It should be mentioned that the latter changes were observed only in patients with 
Helicobacter pylori colonization in gastric mucosa, which was in agreement with the results 
obtained by other authors (Chamouard et al., 1997; Graham et al., 1993; Kozlowski et al., 
1993, 1995; Tzaneva & Julianov, 1999).  
According to literature data, the most numerous neuroendocrine cells of gastric mucosa 
include the following cells: ECL, G, and D, since together they account for over 75% of all 
mucosal endocrine cells in the prepyloric part and corpus of the stomach (Dayal, 1992; 
Fenoglio-Preiser, 1999; Solcia et al., 1975). It can be assumed that the increasing number of 
CgA cells in the prepyloric mucosa means simultaneous increase of G cell count. Therefore, 
the results obtained in own studies may be regarded as a confirmation of the fact already 
known from papers by other authors (Chamouard et al., 1997; Graham et al., 1993; 
Kozlowski et al., 1993, 1995; Tzaneva & Julianov, 1999) and also obtained empirically (Lee et 
al., 1992) which point to participation of disturbances of interrelations between D and G 
cells in the pathomechanism of hypergastrinaemia that accompanies Helicobacter pylori 
colonization of gastric mucosa. It should be stressed that due to other causes, e.g. chronic 
atrophic gastritis in the corpus, the numbers of ECL as well as D cells in hypergastrinaemia 
increase (Borch et al., 1987; Bordi et al., 1987; Carney et al., 1983; Cattan et al., 1989; Hodges 
et al., 1981; Iacangelo et al., 1988), which is accompanied by characteristic vacuolar lesions 
observed under electron microscope in ECL cells (D’Adda et al., 1990; Rubin, 1972). 
Chromogranin A, used, as mentioned above, for identification of neuroendocrine cells, is an 
acid protein of 49 kDa mass located in secretory granules of APUD system cells (Lloyd et al., 
1984; Wiedemann & Huttner, 1989) which belongs to the family of proteins called 
granins/secretogranins. The most important members of this protein family include: 
chromogranin A, B, and secretogranin II (Lloyd et al., 1984). Chromogranin A is present in 
both endocrine and neuroendocrine cells (Cetin, 1992; Iacangelo et al., 1988). It is also 
present in most neuroendocrine tumours and, therefore, is serves as a commonly used 
marker for their identification (Wiedemann et al., 1989). At the same time, it participates in 
the biosynthesis of pancreatostatin (Iacangelo et al., 1988) which inhibits insulin and 
hydrochloric acid secretion. It is worth mentioning that Chromogranin A also binds 
intracellular calcium and catecholamines, significantly regulating intracellular homeostasis 
along this pathway (Iacangelo et al., 1988). It is distributed in neuroendocrine cell granules 
in rather close association with serotonin which is simultaneously connected with both its 
synthesis and accumulation (Tzaneva, 2001).Chromogranin A expression in a significant per 
cent of neuroendocrine cells agrees with argyrophilic reaction e.g. according to Grimelius 
(Cetin, 1992).  
From the standpoint of methodological principles of indentifying individual 
neuroendocrine cell types in humans, an extremely important and frequently forgotten fact 
is that D cells (secreting somatostatin) give no positive argyrophilic reaction according to 
Grimelius, and show no Chromogranin A expression in immunohistochemical reaction 
(Cetin, 1992; Tzaneva, 2001). However, in neuroendocrine aminergic cells the both above 
mentioned colour reactions gave positive results (Cetin, 1992). It is worth mentioning that 
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even purely mathematical calculation of G cell number among CgA cells is more precise 
than analogous mode of ECL cell calculation since only G, D and ECn cells are present in the 
prepyloric part (Bordi et al., 2000; Dayal, 1992; Tzaneva, 2001). 
Decreased D cell count was found in duodenal ulcer with Helicobacter pylori colonization of 
gastric mucosa and in cases of hypergastrinaemia, yet sometimes also in conditions without 
hypergastrinaemia (Zverkov et al., 1996). Many authors are convinced that 
hypergastrinaemia, observed in cases of H.pylori colonization of gastric mucosa, is just 
caused  by reduction of D cell count (Haruma et al., 1995; Kozlowski et al., 1993; Kozlowski 
et al., 1995). No such hypergastrinaemia-inducing effect was observed during activation of 
gastric mucosal inflammatory processes or in biomorphotic process. As regards the course 
of Helicobacter pylori colonization, other authors (Jang & Kim, 2000) found intensification of 
both apoptosis and proliferative activity of endocrine cells, mainly G and D, correlated with 
gastritis activity and with the degree of H.pylori colonization. Not all authors (Tzaneva & 
Julianov, 1999) found lesions in CgA and D cells of gastric corpus mucosa with H.pylori 
colonization. At the same time, these authors stressed that D cells did not participate in the 
pathomechanism of hypergastrinaemia observed in this case.  
Experimental pathology demonstrates that together with deepening biomorphosis, the 
expression of G cells decreases while D and ECn cells are more numerous (Sandstrom et al., 
1999). However, these relations are not so easy to explain, what has been already reported 
by the authors cited above, due to e.g. the fact that it is not certain whether  pathogenic 
factors other than biomorphosis leading to the above described lesions in G, D and ECn 
cells, can be excluded. The own study confirmed lack of changes in the neuroendocrine cells 
status in the gastric mucosa depending on the biomorphosis.  
Studies of endocrine cells in gastric mucosa and gastrointestinal tract mucosa in general, 
require extensive continuation. However, in order to provide significant progress in medical 
knowldege, it is necessary to standardise, in the first place, the method of quantitative 
assessment of these cells and also to establish a generally accepted strictly histopathological 
classification of chronic gastritis. 
5. Presented results and conclusions 
Helicobacter pylori presence in about 50% of healthy population without any clinical 
symptoms, and in 30% also without any morphological changes in gastric mucosa, requires 
further evaluations, both clinical and pathological. Endoscopic biopsy evaluations have 
firmly indicated that there is a poor correlation between the gastric mucosal appearance and 
histological  indices of superficial and atrophic chronic gastritis. The Sydney System and its 
updated 1994 Houston status of the gastritis classification remains incompletely accepted. 
Many pathological reports on gastritis have individual, non-standard styles, which poorly 
correlates with both clinical symptoms and endoscopic lesions. As chronic gastritis is both 
overdiagnosed and underdiagnosed, a cooperation between clinicians and pathologists in 
diagnostics of a particular type of chronic gastritis is a necessity. Finally, in order  to provide 
significant progress in medical knowledge, it is necessary to standardize, in the first place, 
the clinic-pathological cooperation and the method of quantitative or semi-quantitative 
assessment of the inflammatory and epithelial (histoarchitectural structure) cells of the 
gastric mucosa and also to establish a generally accepted strictly histopathological 
classification of chronic gastritis.  
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